Analyst Price Targets — ROIV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 10, 2026 11:05 am | — | H.C. Wainwright | $33.00 | $27.67 | TheFly | Roivant Sciences price target raised to $33 from $26 at H.C. Wainwright |
| February 9, 2026 1:22 pm | — | Jefferies | $30.00 | $26.45 | TheFly | Roivant Sciences price target raised to $30 from $24 at Jefferies |
| February 9, 2026 11:45 am | — | Guggenheim | $30.00 | $25.82 | TheFly | Roivant Sciences price target raised to $30 from $28 at Guggenheim |
| December 18, 2025 1:30 pm | — | Guggenheim | $28.00 | $22.30 | TheFly | Roivant Sciences price target raised to $28 from $25 at Guggenheim |
| December 15, 2025 11:19 am | David Risinger | Leerink Partners | $32.00 | $22.10 | StreetInsider | Roivant Sciences (ROIV) PT Raised to $32 at Leerink Partners |
| December 12, 2025 2:05 pm | — | H.C. Wainwright | $26.00 | $21.47 | TheFly | Roivant Sciences price target raised to $26 from $23 at H.C. Wainwright |
| November 14, 2025 9:59 am | Yastin Suneja | Guggenheim | $25.00 | $20.56 | StreetInsider | Roivant Sciences (ROIV) PT Raised to $25 at Guggenheim |
| November 11, 2025 9:49 am | David Risinger | Leerink Partners | $29.00 | $21.17 | StreetInsider | Roivant Sciences (ROIV) PT Raised to $29 at Leerink Partners |
| September 18, 2025 12:20 pm | — | Jefferies | $20.00 | $15.47 | TheFly | Roivant Sciences price target raised to $20 from $18 at Jefferies |
| September 18, 2025 12:03 pm | — | Guggenheim | $21.00 | $15.24 | TheFly | Roivant Sciences price target raised to $21 from $15 at Guggenheim |
Latest News for ROIV
Guru Stock PicksDavid Herro has made the following transactions:Reduce in CNH by 1.5%Sold out in XAMS:EXOAdd in TSE:6273 by 1.02%New position in LSE:ULVROakmark
Stock News Nvidia's big test: Nvidia (NVDA) reports after the bell with options implying a 5.6% move â the smallest expected postâearnings swing in at least
Guru Stock PicksPaul Singer has made the following transactions:Reduce in LUV by 8.86%Stock News Meta taps AMD for AI buildout: Meta Platforms (META) signed a m
Stock News Dimon warns on credit cycle: JPMorgan Chase (JPM) CEO Jamie Dimon cautioned that elevated asset prices and growing banking competition echo preâ200
Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the firm's stock in a transaction on Friday, February 13th. The stock was sold at an average price of $26.49, for a total value of $5,298,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,654,597 shares
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ROIV.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.